PE10597A1 - 2-(2-n-alcoxifenil)-purin-6-onas 9 sustituidas - Google Patents

2-(2-n-alcoxifenil)-purin-6-onas 9 sustituidas

Info

Publication number
PE10597A1
PE10597A1 PE1996000045A PE00004596A PE10597A1 PE 10597 A1 PE10597 A1 PE 10597A1 PE 1996000045 A PE1996000045 A PE 1996000045A PE 00004596 A PE00004596 A PE 00004596A PE 10597 A1 PE10597 A1 PE 10597A1
Authority
PE
Peru
Prior art keywords
formula
linear
substituted
group
alcoxifenil
Prior art date
Application number
PE1996000045A
Other languages
English (en)
Inventor
Erwin Bischoff
Helmuth Schutz
Matthias Schramm
Ulrich Niewohner
Elisabeth Perzborn
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of PE10597A1 publication Critical patent/PE10597A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28Oxygen atom
    • C07D473/30Oxygen atom attached in position 6, e.g. hypoxanthine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

SE REFIERE AL COMPUESTO DE FORMULA I, DONDE A=R1,R2,R3,R4 Y R5;R6,R7 Y R8 o -(CH2)a-CH3 SIENDO a=9,10,11,12,13,14 o 15. R1,R23 Y R24=ALQUILO LINEAL O RAMIFICADO SUSTITUIDO POR FENILO SUSTITUIDO POR UN GRUPO DE FORMULA -SO2-NR9R10, ENTRE OTROS; R9 Y R10 =H, FENILO, ENTRE OTROS; R2=H, AZIDO, ENTRE OTROS; R3=H;R2 Y R3 FORMAN UN RESTO DE FORMULA =0 o =N-OR20; R20=H, ENTRE OTROS; R7=ALQUILO LINEAL O RAMIFICADO SUSTITUIDO POR UN GRUPO DE FORMULA -NR23R24; R4,R5,R6 Y R8=H,ALQUILO LINEAL O RAMIFICADO. D=H O UN GRUPO DE FORMULA -SO2-NR27R28. E=ALQUILO LINEAL O RAMIFICADO CON HASTA 5 ATOMOS DE CARBONO Y SUS TAUTOMEROS Y SALES. TAMBIEN SE REFIERE AL PROCESO DE PREPARACION DE LA FORMULA I, QUE COMPRENDE LA CICLACION DE SUS SUSTITUYENTES A,E Y D. SE USA PARA EL TRATAMIENTO DE INFLAMACIONES, ENFERMEDADES TROMBOEMBOLICAS, CARDIACAS/CIRCULATORIAS
PE1996000045A 1995-01-19 1996-01-19 2-(2-n-alcoxifenil)-purin-6-onas 9 sustituidas PE10597A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19501480A DE19501480A1 (de) 1995-01-19 1995-01-19 9-substituierte 2-(2-n-Alkoxyphenyl)-purin-6-one

Publications (1)

Publication Number Publication Date
PE10597A1 true PE10597A1 (es) 1997-06-13

Family

ID=7751828

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1996000045A PE10597A1 (es) 1995-01-19 1996-01-19 2-(2-n-alcoxifenil)-purin-6-onas 9 sustituidas

Country Status (30)

Country Link
US (1) US5866571A (es)
EP (1) EP0722943A1 (es)
JP (1) JPH08231546A (es)
KR (1) KR960029335A (es)
CN (1) CN1138583A (es)
AR (1) AR002704A1 (es)
AU (1) AU4097796A (es)
BG (1) BG61729B1 (es)
BR (1) BR9600149A (es)
CA (1) CA2167349A1 (es)
CO (1) CO4700524A1 (es)
CZ (1) CZ16896A3 (es)
DE (1) DE19501480A1 (es)
EE (1) EE9600020A (es)
FI (1) FI960226A (es)
HR (1) HRP960009A2 (es)
HU (1) HUP9600107A3 (es)
IL (1) IL116771A (es)
MA (1) MA23779A1 (es)
NO (1) NO960221L (es)
NZ (1) NZ280829A (es)
PE (1) PE10597A1 (es)
PL (1) PL312353A1 (es)
SG (1) SG47379A1 (es)
SK (1) SK7696A3 (es)
SV (1) SV1996000004A (es)
TN (1) TNSN96005A1 (es)
TR (1) TR199600701A2 (es)
YU (1) YU2896A (es)
ZA (1) ZA96399B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6064072A (en) * 1997-05-12 2000-05-16 Cymer, Inc. Plasma focus high energy photon source
DE19838300A1 (de) * 1998-08-24 2000-03-02 Bayer Ag 9-Dialkylaminopurinon-derivate
US6124303A (en) * 1998-09-11 2000-09-26 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to 9-substituted 2-(2-N-aloxyphenyl) purin-6-ones
US6268372B1 (en) 1998-09-11 2001-07-31 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to 2,9-disubstituted purin-6-ones
GB9924020D0 (en) * 1999-10-11 1999-12-15 Pfizer Ltd Pharmaceutically active compounds
AUPQ515700A0 (en) * 2000-01-19 2000-02-10 Fujisawa Pharmaceutical Co., Ltd. Imidazole compounds
CA2420461C (en) * 2000-09-06 2008-08-12 Tanabe Seiyaku Co., Ltd. Preparations for oral administration
DE60236850D1 (de) * 2001-02-15 2010-08-12 Mitsubishi Tanabe Pharma Corp Tabletten, die in der mundhöhle schnell zerfallen
US6479493B1 (en) 2001-08-23 2002-11-12 Cell Pathways, Inc. Methods for treatment of type I diabetes
EP1454897B1 (en) * 2001-12-13 2007-10-10 Asubio Pharma Co., Ltd. Pyrazolopyrimidinone derivatives having pde7-inhibitory activity
US7208516B2 (en) 2002-03-20 2007-04-24 Celgene Corporation Methods of the treatment of psoriatic arthritis using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
US7893101B2 (en) 2002-03-20 2011-02-22 Celgene Corporation Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof
US6962940B2 (en) 2002-03-20 2005-11-08 Celgene Corporation (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
US7276529B2 (en) 2002-03-20 2007-10-02 Celgene Corporation Methods of the treatment or prevention of exercise-induced asthma using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
EP1494997A4 (en) * 2002-04-05 2007-04-11 Merck & Co Inc SUBSTITUTED ARYLAMID
JP6687550B2 (ja) 2014-06-23 2020-04-22 セルジーン コーポレイション 肝疾患又は肝機能異常を治療するためのアプレミラスト

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4451478A (en) * 1982-03-12 1984-05-29 Newport Pharmaceuticals International, Inc. Imidazole compounds
CA1303037C (en) * 1987-02-02 1992-06-09 Smith Kline & French Laboratories Limited Purinone derivatives as bronchodilators vasodilators and anti-allergic agents
GB8817651D0 (en) * 1988-07-25 1988-09-01 Smith Kline French Lab Chemical compounds
GB9126260D0 (en) * 1991-12-11 1992-02-12 Pfizer Ltd Therapeutic agents
US5294612A (en) * 1992-03-30 1994-03-15 Sterling Winthrop Inc. 6-heterocyclyl pyrazolo [3,4-d]pyrimidin-4-ones and compositions and method of use thereof
US5734053A (en) * 1992-06-26 1998-03-31 Pfizer Inc Purinone antianginal agents
GB9213623D0 (en) * 1992-06-26 1992-08-12 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
DE19501480A1 (de) 1996-07-25
FI960226A0 (fi) 1996-01-17
HU9600107D0 (en) 1996-03-28
EP0722943A1 (de) 1996-07-24
NZ280829A (en) 1998-04-27
AU4097796A (en) 1996-07-25
PL312353A1 (en) 1996-07-22
FI960226A (fi) 1996-07-20
SV1996000004A (es) 1997-02-19
CZ16896A3 (en) 1996-08-14
KR960029335A (ko) 1996-08-17
AR002704A1 (es) 1998-04-29
CN1138583A (zh) 1996-12-25
TNSN96005A1 (en) 2005-03-15
YU2896A (sh) 1999-03-04
IL116771A (en) 1999-06-20
NO960221L (no) 1996-07-22
NO960221D0 (no) 1996-01-18
MA23779A1 (fr) 1996-10-01
EE9600020A (et) 1996-08-15
HUP9600107A3 (en) 1999-06-28
SK7696A3 (en) 1996-08-07
HUP9600107A2 (en) 1997-05-28
US5866571A (en) 1999-02-02
SG47379A1 (en) 1998-04-17
HRP960009A2 (en) 1997-12-31
IL116771A0 (en) 1996-05-14
TR199600701A2 (tr) 1996-08-21
ZA96399B (en) 1996-08-14
CA2167349A1 (en) 1996-07-20
BR9600149A (pt) 1998-01-06
BG61729B1 (bg) 1998-04-30
JPH08231546A (ja) 1996-09-10
BG100291A (bg) 1996-07-31
CO4700524A1 (es) 1998-12-29

Similar Documents

Publication Publication Date Title
PE10597A1 (es) 2-(2-n-alcoxifenil)-purin-6-onas 9 sustituidas
LU91587I2 (fr) Agomélatine et ses dérivés pharmaceutiquement acceptables (VALDOXAN)
DE69010375T2 (de) Protease-Hemmer.
DK160877C (da) Fremgangsmaade til fremstilling af 2-penemforbindelser
FI874570A (fi) Antibakteriska medel -ii.
MX169453B (es) Procedimiento para la preparacion de acidos alfa-arilcanoicos opticamente activos y sus intermediarios
DE60002512D1 (de) Aufzeichnungsmaterial sowie Bilddruckverfahren das dieses Material verwendet
ES517637A0 (es) Un procedimiento de preparacion de los acidos(oxo-4-4h-(1)-benzopiran-8-il)-alcanoicos.
FR2375213A1 (fr) Polyalkylpiperidines utilisables comme stabilisants de matieres plastiques
ATE93232T1 (de) Bis(methylendioxy)biphenyl-verbindungen.
MX9401209A (es) Derivados de 2-amido-4-feniltiazoles polisubstituidos.
SE7602144L (sv) Kvaternera imidazoliumforeningar
FI834730A (fi) 1-karboxialkanoylperhydro-indol-2- karboxylsyror och deras derivat.
DK400781A (da) Fremgangsmaade til fremstilling af 2-(1,4-benzodioxan-2-ylalkyl) imidazoler
SE7605190L (sv) Nya tiazoliner
AR012847A1 (es) Compuestos derivados de eritromicina, composiciones farmaceuticas, procedimientos de tratamiento con dichos compuestos, procedimiento parapreparar dichos compuestos
ATE146481T1 (de) Epoxysuccinamidsäurederivat
SE8404297D0 (sv) Aminometyl-forening
GB2001061A (en) alpha -Vinyl Amino Acids
FI883134A (fi) Fluorhaltiga renin-inhibitorer.
FI853685A0 (fi) Nya n-alk(en)yl-n-(o,o-disubstituerade -tiofosforyl)-n'n'-disubstituerade glycinamider, foerfarande foer framstaellning av dessa samt kvalstergifter, insektgifter och svampgifter vilka innehaoller dessa som aktiv bestaondsdel.
FI803706L (fi) Foerfarande foer framstaellning av alkyltiobenzimidazoler
DK82583A (da) Furyloxazolyleddikesyrederivater og fremgangsmaader til fremstilling deraf
SE7706693L (sv) Sett att framstella hydrazinopyridazinderivat
SE7710933L (sv) 5-alkoxi-pikolinsyror

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed